<DOC>
	<DOCNO>NCT01492556</DOCNO>
	<brief_summary>The purpose study determine whether Etoposide Monotherapy effective safe treatment recurrent metastatic breast cancer Chinese female patient .</brief_summary>
	<brief_title>Study Etoposide Treating Patients With Recurrent Metastatic Breast Cancer</brief_title>
	<detailed_description>Current recommend dosage Etoposide treat breast cancer 50 mg/m2 orally day 21 day , repeat every 28 day . With retrospective data review , study intend adjust Etoposide dose 60 mg/m2 daily 10 day , repeat every 21 day cycle , investigate effectiveness safety Etoposide monotherapy treatment recurrent metastatic breast cancer Chinese female patient .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<criteria>Age : 1880 year old . ECOG status : 02 . Histologic cytologic diagnosis locally advance metastatic breast cancer . No three prior chemotherapy , adjuvant chemotherapy exclude . Received prior anthracycline , taxane therapy . At least 4 week previous chemotherapy . Measurable disease &gt; =2 cm ( &gt; =1 cm spiral CT scan ) . Life expectancy ≥ 3 month . Adequate organ function : Hemoglobin ≥10.0 g/dl , Absolute neutrophil count ≥1.5×10^9/L , Platelet count ≥100×10^9/L , Creatinine clearance ≥60ml/min , Bilirubin ≤1.5 time upper limit normal ( ULN ) ; AKP , AST ALT ≤2.5x ULN ( ≤5x ULN due liver metastasis ) . Signed informed consent . Menopausal woman receive surgical sterilization , woman child potential must pregnant nursing negative pregnancy test willing practice acceptable method birth control study 3 month study . Pregnancy lactation . Untreated uncontrolled CNS metastasis , refractory psychiatric illness . Prior treatment Etoposide . Other primary malignancy within past 5 year except carcinoma situ cervix nonmelanoma skin cancer . Clinically significant heart disease ( e.g.congestive heart failure , symptomatic coronary disease , uncontrolled cardiac arrhythmia , Myocardial infarction ) within past 12 month . Serious uncontrolled concurrent infection metabolism disorder . Concurrent treatment active peptic ulcer disease digestive disorder . Prior radiotherapy major surgery within 3 week screen . Less 4 week since prior investigational agent . Metastases present onethird whole liver . Unable unwilling comply study protocol . Unsuitable participate study , opinion treat physician .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Recurrent</keyword>
	<keyword>Metastatic</keyword>
	<keyword>Breast cancer</keyword>
</DOC>